DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/rm6bxd/epicast_report) has announced the addition of the "EpiCast Report: Diabetic Macular Edema - Epidemiology Forecast to 2023" report to their offering.
This report provides an overview of the risk factors, comorbidities, and the global and historical trends for DME, and ME following BRVO and CRVO in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed prevalent cases of DME in the diagnosed diabetic retinopathy population and the total prevalent cases of ME following BRVO and CRVO segmented by sex and age (20-39 years, 40-59 years, 60-79 years, and =80 years) in these markets.
The publisher epidemiologists forecast that the diagnosed prevalent cases of DME in the diagnosed diabetic retinopathy population in the 7MM will increase by 34.2% during the forecast period, from 922,492 cases in 2013 to 1,238,301 cases in 2023. The total prevalent cases of ME following BRVO in the 7MM will increase by 13.7% during the forecast period, from 294,862 cases in 2013 to 335,346 cases in 2023. The total prevalent cases of ME following CRVO in the 7MM will increase by 19.6% during the forecast period, from 114,571 cases in 2013 to 136,973 cases in 2023.
Our epidemiological analysis is supported by the use of country-specific prevalence data from epidemiological studies published in peer-reviewed journals. The publisher epidemiologists used uniform methodology across the markets to forecast the diagnosed prevalent cases of DME in the diagnosed diabetic retinopathy population and the total prevalent cases of ME following BRVO and CRVO, to allow for a meaningful comparison of the disease populations across markets.
Key Topics Covered:
1 Tables & Figures
2 Introduction
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global Trends
3.4 Forecast Methodology
- Forecast Assumptions and Methods Diagnosed Prevalent Cases of Diabetes
- Forecast Assumptions and Methods Diagnosed Prevalent Cases of Diabetic Retinopathy
- Forecast Assumptions and Methods - Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population
- Forecast Assumptions and Methods - Total Prevalent Cases of ME following BRVO and CRVO
3.5 Epidemiological Forecast for Macular Edema (2013-2023)
- Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population
- Age-Specific Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population
- Sex-Specific Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population
- Total Prevalent Cases of ME following BRVO
- Age-Specific Total Prevalent Cases of ME following BRVO
- Sex-Specific Total Prevalent Cases of ME following BRVO
- Total Prevalent Cases of ME following CRVO
- Age-Specific Total Prevalent Cases of ME following CRVO
- Sex-Specific Total Prevalent Cases of ME following CRVO
3.6 Discussion
4 Appendix
For more information visit http://www.researchandmarkets.com/research/rm6bxd/epicast_report
